The ability of animal studies to detect serious post marketing adverse events is limited
Evaluation of cytotoxicity of different tobacco product preparations
Synergetic toxicity of DATR, a recombinant soluble human TRAIL mutant, in combination with traditional chemotherapeutics in rats
The chemical composition of smokeless tobacco: A survey of products sold in the United States in 2006 and 2007
Intra- and inter-individual variability in urinary nicotine excretion and plasma cotinine in adult cigarette smokers
Absence of reproductive and developmental toxicity in rats following exposure to a 20-kHz or 60-kHz magnetic field
Applicability of in vitro tests for skin irritation and corrosion to regulatory classification schemes: Substantiating test strategies with data from routine studies
HSP90 inhibition induces cytotoxicity via down-regulation of Rad51 expression and DNA repair capacity in non-small cell lung cancer cells
Repeated dose (14 days) rat intramuscular toxicology study of Her1 vaccine
Human safety risk assessment of lymph node angiomas observed in 2-year carcinogenicity studies in rats
Lack of human tissue-specific correlations for rodent pancreatic and colorectal carcinogens
Quantitative risk assessment for skin sensitisation: Consideration of a simplified approach for hair dye ingredients
Development of a cancer-based chronic inhalation reference value for hexavalent chromium based on a nonlinear-threshold carcinogenic assessment
2,4-D Exposure and risk assessment: Comparison of external dose and biomonitoring based approaches
Corrigendum to ‘‘An overview of the preclinical toxicity and potential carcinogenicity of sitaxentan (Thelin®), a potent endothelin receptor antagonist developed for pulmonary arterial hypertension” [Regul. Toxicol. Pharmacol. 2012, 95–103],
Derivation of a chronic oral reference dose for cobalt
Risk assessment for consumer exposure to toluene diisocyanate (TDI) derived from polyurethane flexible foam